Poniard Pharmaceuticals, Inc.
PARD · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $16 | $44 | $29 |
| Short-Term Investments | $3 | $27 | $29 | $63 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $5 | $44 | $74 | $94 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $8 | $9 | $10 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $6 | $8 | $10 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12 | $52 | $84 | $105 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $9 | $8 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $8 | $11 | $5 |
| Total Curr. Liab. | $2 | $17 | $19 | $9 |
| LT Debt | $2 | $12 | $17 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $12 | $17 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $0 | $0 |
| Total Liabilities | $3 | $29 | $37 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$439 | -$408 | -$362 | -$313 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $446 | $431 | $409 | $401 |
| Total Equity | $8 | $24 | $48 | $89 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12 | $52 | $84 | $105 |
| Net Debt | $0 | $4 | -$19 | -$19 |